CO5130019A1 - Tabletas masticables suaves comprimidas y de forma convexa y proceso para su preparacion - Google Patents

Tabletas masticables suaves comprimidas y de forma convexa y proceso para su preparacion

Info

Publication number
CO5130019A1
CO5130019A1 CO99052293A CO99052293A CO5130019A1 CO 5130019 A1 CO5130019 A1 CO 5130019A1 CO 99052293 A CO99052293 A CO 99052293A CO 99052293 A CO99052293 A CO 99052293A CO 5130019 A1 CO5130019 A1 CO 5130019A1
Authority
CO
Colombia
Prior art keywords
convex
cheatable
tablets
preparation
mixtures
Prior art date
Application number
CO99052293A
Other languages
English (en)
Inventor
L Robinson Ronni
James R Damon
James R Mossop
Michael D Palmer
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of CO5130019A1 publication Critical patent/CO5130019A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Abstract

La presente invención se relaciona con una tableta masticable comprimida que tiene superficies principales opuestas, que comprende: por lo menos un ingrediente activo recubierto con un recubrimiento enmascarador de sabor; un carbohidrato comprimible y desintegrable en agua seleccionado del grupo que consiste de manitol, sorbitol, maltitol, dextrosa, sacarosa, xilitol, lactosa y mezclas de los mismos y un aglutinante seleccionado del grupo que consiste de celulosa, derivados celulósicos, polivinilpirrolidona, almidón modificado y mezclas de los mismos, dichas superficies principales tienen una forma convexa y dicha tableta tiene una dureza de aproximadamente 2 a aproximadamente 11 kp/cm2 y una friabilidad de menos de aproximadamente 1 %.
CO99052293A 1998-08-18 1999-08-18 Tabletas masticables suaves comprimidas y de forma convexa y proceso para su preparacion CO5130019A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/135,723 US6270790B1 (en) 1998-08-18 1998-08-18 Soft, convex shaped chewable tablets having reduced friability

Publications (1)

Publication Number Publication Date
CO5130019A1 true CO5130019A1 (es) 2002-02-27

Family

ID=22469364

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99052293A CO5130019A1 (es) 1998-08-18 1999-08-18 Tabletas masticables suaves comprimidas y de forma convexa y proceso para su preparacion

Country Status (17)

Country Link
US (3) US6270790B1 (es)
EP (1) EP0997143B1 (es)
JP (1) JP2000095673A (es)
KR (1) KR20000017352A (es)
CN (1) CN1249176A (es)
AR (1) AR022065A1 (es)
AT (1) ATE381320T1 (es)
AU (1) AU773549B2 (es)
BR (1) BR9903736A (es)
CA (1) CA2280628C (es)
CO (1) CO5130019A1 (es)
DE (1) DE69937780T2 (es)
ES (1) ES2299234T3 (es)
NZ (1) NZ337310A (es)
PT (1) PT997143E (es)
SA (1) SA99200655B1 (es)
ZA (1) ZA995248B (es)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6270790B1 (en) * 1998-08-18 2001-08-07 Mxneil-Ppc, Inc. Soft, convex shaped chewable tablets having reduced friability
US20040102486A1 (en) * 1998-11-12 2004-05-27 Smithkline Beecham Corporation Novel method of treatment
US20040081697A1 (en) * 1998-11-12 2004-04-29 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
US20020122823A1 (en) * 2000-12-29 2002-09-05 Bunick Frank J. Soft tablet containing dextrose monohydrate
EP1390015A1 (en) * 2001-05-31 2004-02-25 Cima Labs Inc. Taste-masking of highly water-soluble drugs
DE60232445D1 (de) * 2001-06-28 2009-07-09 Ucb Farchim Sa Cetirizin und pseudoephedrin enthaltende tablette
US20030060422A1 (en) * 2001-08-31 2003-03-27 Balaji Venkataraman Tannate compositions and methods of treatment
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
KR100446153B1 (ko) * 2001-10-24 2004-08-30 한국유나이티드제약 주식회사 가용화된 이부프로펜 함유 제제의 조성물 및 그의 제조방법
FR2831820B1 (fr) * 2001-11-05 2004-08-20 Ethypharm Sa Comprime orodispersible presentant une grande homogeneite et son procede de preparation
FR2833173B1 (fr) * 2001-12-10 2004-08-27 Roquette Freres Preparation antipyretique renfermant du xylitol
WO2003080023A2 (en) * 2002-03-20 2003-10-02 Elan Pharma International Limited Fast dissolving dosage forms having reduced friability
ATE388693T1 (de) 2002-04-04 2008-03-15 Pfizer Prod Inc Wohlschmeckende kautablette
ES2767173T3 (es) 2002-08-13 2020-06-16 Intervet Int Bv Composiciones y proceso para administrar un aditivo
AU2003299568B2 (en) 2002-11-27 2010-07-22 Ampio Pharmaceuticals, Inc. Treatment of diseases and conditions mediated by increased phosphorylation
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
US20040265373A1 (en) * 2003-06-27 2004-12-30 David Wynn Soft tablet containing high molecular weight cellulosics
US20040265372A1 (en) * 2003-06-27 2004-12-30 David Wynn Soft tablet containing high molecular weight cellulosics
SG145765A1 (en) * 2003-08-26 2008-09-29 Shire Holdings Ag Pharmaceutical formulation comprising lanthanum compounds
US7282217B1 (en) * 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
CN1886126A (zh) * 2003-09-25 2006-12-27 Dmi生物科学公司 利用n－酰基－l－天冬氨酸的方法和产品
US20050095299A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US20050095300A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
JP2007532571A (ja) * 2004-04-07 2007-11-15 インターベツト・インターナシヨナル・ベー・ベー ベンズイミダゾール、アベルメクチンおよびプラジカンテルの有効組成物および関連する使用方法
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
HUE031470T2 (en) 2004-11-24 2017-07-28 Meda Pharmaceuticals Inc Preparations and methods of use containing azelastine
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
CN1686089B (zh) * 2005-05-08 2010-08-18 北京健健康康生物技术有限公司 一种可直接压片的木糖醇颗粒及其制备方法
WO2007007659A1 (ja) * 2005-07-08 2007-01-18 Takeda Pharmaceutical Company Limited 錠剤
US20070020186A1 (en) 2005-07-22 2007-01-25 Alpex Pharma S.A. Solid dosage formulations of narcotic drugs having improved buccal adsorption
US20070077300A1 (en) * 2005-09-30 2007-04-05 Wynn David W Oral compositions containing a salivation inducing agent
US20070128251A1 (en) * 2005-12-07 2007-06-07 Piedmont Pharmaceuticals, Inc. Process for manufacturing chewable dosage forms for drug delivery and products thereof
FR2898056B1 (fr) 2006-03-01 2012-01-20 Ethypharm Sa Comprimes resistant a l'ecrasement destines a eviter le detournement illicite
US20070251352A1 (en) * 2006-05-01 2007-11-01 Pruitt Judith G Pelletized Feed Material for Biomass Generator
WO2007144902A1 (en) * 2006-06-12 2007-12-21 Jubliant Organosys Limited Chewable bilayer tablet formulation
WO2008094877A2 (en) * 2007-01-30 2008-08-07 Drugtech Corporation Compositions for oral delivery of pharmaceuticals
KR101109633B1 (ko) 2007-08-03 2012-01-31 제이더블유중외제약 주식회사 활성성분의 코팅막이 보호되는 구강내붕해제형을 제조하기위한 조성물
CA2930063C (en) 2008-01-04 2017-01-31 Schabar Research Associates Llc Unit oral solid dose compositions composed of naproxen sodium and nizatidine
US20100009012A1 (en) * 2008-07-11 2010-01-14 Zukkoor N David Chewable pharyngeal inflammation symptom relief composition
WO2010077878A1 (en) * 2008-12-15 2010-07-08 Fleming And Company, Pharmaceuticals Rapidly dissolving vitamin formulation and methods of using the same
US20100278913A1 (en) * 2009-04-30 2010-11-04 Sancilio & Company Chewable tablet
EP3064064A1 (en) 2009-09-30 2016-09-07 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
US20110142942A1 (en) * 2009-12-10 2011-06-16 Monosol Rx, Llc USE OF pH SENSITIVE COMPOUNDS IN TASTE MASKING OF DRUG SUBSTANCES WITHIN ORAL THIN FILM STRIPS
JP5771381B2 (ja) * 2010-10-22 2015-08-26 アサヒフードアンドヘルスケア株式会社 乾燥酵母を含有する錠剤
USD697510S1 (en) * 2011-03-23 2014-01-14 Brother Industries, Ltd. Scanner with projector
WO2014033230A1 (fr) 2012-08-31 2014-03-06 Friulchem Spa Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations
JP6290081B2 (ja) 2011-09-15 2018-03-07 フリウルケム、ソシエタ、ペル、アチオニＦｒｉｕｌｃｈｅｍ Ｓｐａ 動物への経口投与用組成物、その製造方法およびその使用
WO2013068371A1 (en) 2011-11-08 2013-05-16 Intervet International B.V. Soft chewable dosage form compositions of cannabinoid receptor type 1 (cb-1) antagonists
CN104168900A (zh) 2012-02-06 2014-11-26 梅里亚有限公司 包含全身性地起作用的活性剂的杀寄生虫口服兽用组合物、方法及其用途
EP2833867B2 (en) 2012-04-04 2023-05-10 Intervet International B.V. Solid oral pharmaceutical compositions for isoxazoline compounds
PL2861236T3 (pl) 2012-06-15 2020-03-31 Pharmathen S.A. Kompozycja farmaceutyczna zawierająca polimer wiążący fosforany
US9532946B2 (en) 2012-11-20 2017-01-03 Intervet Inc. Manufacturing of semi-plastic pharmaceutical dosage units
EP3446685A1 (en) 2012-11-30 2019-02-27 Acura Pharmaceuticals, Inc. Self-regulated release of active pharmaceutical ingredient
US9642811B2 (en) 2014-03-26 2017-05-09 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release biphasic matrix solid dosage form
WO2016033424A1 (en) 2014-08-29 2016-03-03 Genzyme Corporation Methods for the prevention and treatment of major adverse cardiovascular events using compounds that modulate apolipoprotein b
CN104490804A (zh) * 2014-12-05 2015-04-08 海南卫康制药(潜山)有限公司 一种西咪替丁组合物咀嚼片及其制备方法
EP3061501A1 (en) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
EP3117825A1 (en) 2015-07-16 2017-01-18 Rottapharm S.p.A. Oral formulation comprising berberine and morus alba extract
US11103581B2 (en) 2015-08-31 2021-08-31 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
US20190022013A1 (en) 2015-12-19 2019-01-24 First Time Us Generics Llc Soft-chew tablet pharmaceutical formulations
WO2017106812A1 (en) 2015-12-19 2017-06-22 First Time Us Generics Llc Soft-chew tablet pharmaceutical formulations
WO2017151571A1 (en) * 2016-02-29 2017-09-08 First Time Us Generics Llc Abuse deterrent soft chewable drug formulations
US20190110985A1 (en) 2016-05-12 2019-04-18 Bayer Animal Health Gmbh Process for preparing shaped articles for administration to animals
US10323226B2 (en) 2017-03-30 2019-06-18 Nch Corporation Feed material for biomass generator
US11033502B2 (en) * 2017-06-27 2021-06-15 Daiichi Sankyo Company, Limited Tablet
EP3878436A1 (en) 2020-03-09 2021-09-15 Bayer Animal Health GmbH Soft chewable formed body for the administration to animals
EP4181912A1 (en) 2020-07-15 2023-05-24 Schabar Research Associates LLC Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn
CA3124579A1 (en) 2020-07-15 2022-01-15 Schabar Research Associates Llc Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn
CA3201608A1 (en) 2020-12-18 2022-06-23 Boehringer Ingelheim Animal Health USA Inc. Boron containing pyrazole compounds, compositions comprising them, methods and uses thereof
IT202100016310A1 (it) * 2021-06-22 2022-12-22 Alaia Idea S R L Metodo per la produzione di compresse
US20230123099A1 (en) * 2021-10-15 2023-04-20 Fertin Pharma A/S Dextrose tablets with improved mouthfeel

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3431339A (en) * 1966-07-20 1969-03-04 Colgate Palmolive Co Dentifrices
US3619292A (en) * 1968-07-15 1971-11-09 Penick & Ford Ltd Tablets and method of forming
GB8426152D0 (en) * 1984-10-16 1984-11-21 Reckitt & Colmann Prod Ltd Medicinal compositions
CA1259924A (en) * 1985-03-25 1989-09-26 Wallace E. Becker Pharmaceutical tableting method
US4760094A (en) * 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
US5536526A (en) * 1988-01-11 1996-07-16 Cultor Ltd. Xylitol-based binding and diluting agent and a process for the production thereof
US4866046A (en) * 1988-05-31 1989-09-12 Top Laboratories, Inc. Low-dosage sublingual aspirin
US5275823A (en) * 1989-04-27 1994-01-04 Smith Kline & French Laboratories Ltd. Pharmaceutical compositions
US5460825A (en) * 1990-05-23 1995-10-24 Mcneil-Ppc, Inc. Taste mask coatings for preparing chewable pharmaceutical tablets
US5075114A (en) 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
CA2068402C (en) 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
US5464632C1 (en) 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
DK71993D0 (da) * 1993-06-18 1993-06-18 Novo Nordisk As Enzym
CA2128820A1 (en) * 1993-07-27 1995-01-28 Walter G. Gowan, Jr. Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
US5609883A (en) 1994-09-16 1997-03-11 Advanced Technology Pharmaceuticals Corporation Compressed tablet transitory lubricant system
US5529783A (en) * 1994-12-19 1996-06-25 Mcneil-Ppc, Inc. Rotor granulation and coating of acetaminophen, pseudoephedrine, chlorpheniramine, and, optionally dextromethorphan
US5686107A (en) * 1995-01-30 1997-11-11 Fmc Corporation Chewable pharmaceutical tablets
US6224905B1 (en) * 1996-06-17 2001-05-01 Janssen Pharmaceutica N.V. Biconvex rapidly disintegrating dosage forms
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
US6270790B1 (en) * 1998-08-18 2001-08-07 Mxneil-Ppc, Inc. Soft, convex shaped chewable tablets having reduced friability

Also Published As

Publication number Publication date
CA2280628A1 (en) 2000-02-18
BR9903736A (pt) 2000-09-26
ATE381320T1 (de) 2008-01-15
ES2299234T3 (es) 2008-05-16
NZ337310A (en) 2000-05-26
SA99200655B1 (ar) 2006-08-22
EP0997143B1 (en) 2007-12-19
US6471991B2 (en) 2002-10-29
CN1249176A (zh) 2000-04-05
PT997143E (pt) 2008-02-07
US20030049316A1 (en) 2003-03-13
US6270790B1 (en) 2001-08-07
CA2280628C (en) 2009-02-10
AR022065A1 (es) 2002-09-04
ZA995248B (en) 2001-02-19
KR20000017352A (ko) 2000-03-25
AU4456599A (en) 2000-03-09
US7029699B2 (en) 2006-04-18
JP2000095673A (ja) 2000-04-04
DE69937780D1 (de) 2008-01-31
EP0997143A2 (en) 2000-05-03
EP0997143A3 (en) 2001-11-14
US20010043947A1 (en) 2001-11-22
DE69937780T2 (de) 2008-12-04
AU773549B2 (en) 2004-05-27

Similar Documents

Publication Publication Date Title
CO5130019A1 (es) Tabletas masticables suaves comprimidas y de forma convexa y proceso para su preparacion
ES2560901T3 (es) Preparaciones recubiertas de azúcar duro, soluciones de recubrimiento de azúcar y procedimiento para producir preparaciones recubiertas de azúcar duro
ES2164424T3 (es) Preparacion farmaceutica solida.
AR025426A1 (es) Sales farmaceuticas de la sustancia activa tramadol y al menos un edulcorante, medicamentos que contienen estas sales, el uso de estas sales para lapreparacion de medicamentos y formas de administracion que contienen esas sales
ES2187822T3 (es) Comprimidos de disgregacion rapida.
AR002275A1 (es) Forma de dosificacion farmaceutica oral, procedimiento para la manufactura de una forma de dosificacion fija, y uso de dicha forma de dosificacionfarmaceutica oral.
KR870005637A (ko) 약물 데포
DE69001730D1 (de) Pastenfoermige, waesserige pharmazeutische zusammensetzungen.
AR026560A1 (es) Recubrimiento
AR018410A1 (es) Uso de una composicion para la manufactura de un medicamento que se usa para la prevencion o tratamiento de un estado agudo de asma y/o asma intermitentey/o episodios de asma cronico y metodo para la prevencion o tratamiento de un estado agudo de asma y/o asma intermitente y/o episodios de asma cron
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
WO2009006095A3 (en) Dual portion lozenge dosage form
AR030068A1 (es) Composiciones farmaceuticas para el tratamiento de condiciones dolorosas, inflamatorias y ulcerosas de superficies epiteliales humedas como por ejemplo mucositis, estomatitis y sindrome de behcet
AR033796A1 (es) Composicion farmaceutica
BR9912979B1 (pt) composição farmacêutica administrável oralmente, tablete de mascar, cápsula e uso de chitosan.
BR9917012A (pt) Comprimido matricial, permitindo a liberação prolongada de gliclazida, após administração por via oral
RS50937B (sr) Farmaceutska kompozicija koja sadrži metformin i glibenklamid za lečenje šećerne bolesti tipa ii
WO2004075875A8 (en) Dosage form having a saccharide matrix
EP0992240A4 (en) THERAPEUTIC AGENT FOR TREATING ANERECTION
DK1171101T3 (da) Fremgangsmåde til fremstilling af en vanduoplöselig amorf depotmatrix
BR0107899A (pt) Processo para produzir uma preparação de ingrediente ativo compreendendo ibuprofeno, preparação de ingrediente ativo, uso da mesma, preparação farmacêutica, uso da mesma, processo para produzir formas de dosagem sólidas, e, forma de dosagem sólida
AR031649A1 (es) Composicion farmaceutica de dronedarona para administracion parenteral
SE8901003L (sv) Snabbloesliga preparat
BR8803630A (pt) Processo para a preparacao de um composto,agente de combate a pragas,aplicacao e processo para o combate de pragas
ES2191638T3 (es) Comprimidos escasamente dosificados y procedimiento para su preparacion.